13C/15N-Enriched l -Dopa as a Triple-Resonance NMR Probe to Monitor Neurotransmitter Dopamine in the Brain and Liver Extracts of Mice

HANDLE オープンアクセス

抄録

In an attempt to monitor μm-level trace constituents, we applied here 1H-{13C-15N} triple-resonance nuclear magnetic resonance (NMR) to 13C/15N-enriched l-Dopa as the inevitable precursor of the neurotransmitter dopamine in the brain. The perfect selectivity (to render endogenous components silent) and μm-level sensitivity (700 MHz spectrometer equipped with a cryogenic probe) of triple-resonance allowed the unambiguous and quantitative metabolic and pharmacokinetic analyses of administered l-Dopa/dopamine in the brain and liver of mice. The level of dopamine generated in the brain (within the range 7-76 μm, which covers the typical stimulated level of -30 μm) could be clearly monitored ex vivo, but was slightly short of the detection limit of a 7 T MR machine for small animals. This work suggests that μm-level trace constituents are potential targets of ex vivo monitoring as long as they contain N atom(s) and their appropriate 13C/15N-enrichment is synthetically accessible. Traces via triple resonance! Tripleresonance high-resolution NMR with a cryogenic probe at 16.4 T is sensitive and selective enough to perform quantitative metabolic/pharmacokinetic analysis of l-Dopa/dopamine in brain and liver extracts from mice. This work suggests that μm-level trace constituents are potential targets of ex vivo monitoring as long as they contain N atoms and their appropriate 13C/15N-enrichment is synthetically accessible.

収録刊行物

  • ChemistryOpen

    ChemistryOpen 5 (2), 125-128, 2016-04-01

    Wiley-VCH Verlag

詳細情報 詳細情報について

  • CRID
    1050282810814964480
  • NII論文ID
    120005844253
  • ISSN
    21911363
  • HANDLE
    2433/216667
  • 本文言語コード
    en
  • 資料種別
    journal article
  • データソース種別
    • IRDB
    • CiNii Articles

問題の指摘

ページトップへ